Pharmajet

Pharmajet company information, Employees & Contact Information

Explore related pages

Related company profiles:

The PharmaJet mission is to improve the performance and outcomes of injectables with our enabling technology that better activates the immune system. We are committed to helping our partners realize their research and commercialization goals while making an impact on public health. PharmaJet Precision Delivery Systems provide increased vaccine effectiveness, a preferred patient and caregiver experience, and offer a proven path to commercialization. They are also safe, fast, and easy-to-use. The Stratis System has U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The Tropis System has CE Mark and WHO PQS certification for intradermal injections. They are both commercially available for global immunization programs.

Company Details

Employees
33
Founded
-
Address
400 Corporate Circle,
Phone
3035264052
Email
in****@****jet.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Golden, CO
Looking for a particular Pharmajet employee's phone or email?

Pharmajet Questions

News

PharmaJet® Tropis® Needle-Free Injection System Selected for Polio Immunization Campaign in Pakistan - Morningstar

PharmaJet® Tropis® Needle-Free Injection System Selected for Polio Immunization Campaign in Pakistan Morningstar

Immuno Cure and PharmaJet collaborate to advance a novel HIV therapeutic DNA vaccine using needle-free technology in humans - European AIDS Treatment Group

Immuno Cure and PharmaJet collaborate to advance a novel HIV therapeutic DNA vaccine using needle-free technology in humans European AIDS Treatment Group

PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference - FinancialContent

PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference FinancialContent

PharmaJet® Enters into MOU Agreement with Egyptian UPA and EVA Pharma to provide Needle-free Delivery for Routine Immunization in Egypt - Yahoo Finance

PharmaJet® Enters into MOU Agreement with Egyptian UPA and EVA Pharma to provide Needle-free Delivery for Routine Immunization in Egypt Yahoo Finance

CORRECTING and REPLACING Polio Vaccination Campaign Planned in Afghanistan with PharmaJet® Tropis® ID Delivery System - Yahoo Finance

CORRECTING and REPLACING Polio Vaccination Campaign Planned in Afghanistan with PharmaJet® Tropis® ID Delivery System Yahoo Finance

PharmaJet, Nigeria’s National Primary Health Care Development Agency, and Health-focused Consortium Begin Implementation of Study Using Tropis® ID for Routine Immunization - The AI Journal

PharmaJet, Nigeria’s National Primary Health Care Development Agency, and Health-focused Consortium Begin Implementation of Study Using Tropis® ID for Routine Immunization The AI Journal

PharmaJet Appoints Paul LaBarre as VP - citybiz

PharmaJet Appoints Paul LaBarre as VP citybiz

PharmaJet to Highlight Benefits of Needle-free Intradermal Delivery at Medical Conference in Ethiopia - Business Wire

PharmaJet to Highlight Benefits of Needle-free Intradermal Delivery at Medical Conference in Ethiopia Business Wire

and Immuno Cure Sign Agreement for Clinical Development of a Needle-free HIV Therapeutic DNA Vaccine - Business Wire

and Immuno Cure Sign Agreement for Clinical Development of a Needle-free HIV Therapeutic DNA Vaccine Business Wire

PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology Solutions - Business Wire

PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology Solutions Business Wire

PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines - Business Wire

PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines Business Wire

Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine - Business Wire

Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine Business Wire

Marie Mazur Appointed Chair of PharmaJet Board of Directors - Business Wire

Marie Mazur Appointed Chair of PharmaJet Board of Directors Business Wire

PharmaJet Partner Zydus Cadila Announces Emergency Use Authorization Approval for World’s First Plasmid DNA COVID-19 Vaccine - Business Wire

PharmaJet Partner Zydus Cadila Announces Emergency Use Authorization Approval for World’s First Plasmid DNA COVID-19 Vaccine Business Wire

PharmaJet Partner Immunomic Therapeutics Receives FDA Fast Track Designation for pDNA Vaccine for Skin Cancer - FinancialContent

PharmaJet Partner Immunomic Therapeutics Receives FDA Fast Track Designation for pDNA Vaccine for Skin Cancer FinancialContent

Top Pharmajet Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant